At the time I entered my hematology/oncology fellowship, I was eager to pursue clinical research in the area of cancer-associated thrombosis. I chose to study the venous thromboembolism characteristics of individuals from our institution who received stem cell transplantation, focusing on differences between cord blood and non-cord blood recipients. I discovered that not only was post-transplant thrombosis a serious problem, but that these patients were also at an extremely high risk of bleeding with anticoagulation. As a result of this endeavor, I have developed a career interest aimed at developing tools to risk stratify complex patients regarding their risk for bleeding and clotting simultaneously.
As my career has progressed, I have also discovered a passion for the treatment of women with bleeding disorders which has led to a goal of balancing our knowledge and understanding of bleeding disorders across genders.
I continue to pursue the development of novel tools to aid in bleeding and clotting risk stratification while also spending time investigating these knowledge gaps regarding how to best care for women, transgender, and gender non-binary individuals with disorders of hemostasis.
For Referring Providers: